Cases & Deals

  • Home
  • Practices
  • Astellas Pharma acquires Ogeda SA for €800 million (US$852 million)

Share

Astellas Pharma acquires Ogeda SA for €800 million (US$852 million)

May 2017

Client(s) Astellas Pharma Inc.

Jones Day advised Astellas Pharma Inc., a Japanese leader in the pharma industry, in its €800 million (US$852 million) acquisition of Ogeda SA, a privately owned Belgian drug discovery company.

In addition to M&A representation, Jones Day provided antitrust and intellectual property advice regarding this transaction.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.